Keyphrases
Poor Prognosis
100%
Single nucleotide Polymorphism
100%
Sema3A
100%
SEMA3B
100%
Prostate Cancer Risk
100%
Semaphorin3A
100%
Risk Prognosis
100%
Hispanic
50%
Prostate Cancer
50%
White People
50%
Hispanic Men
50%
Prostate Cancer Prognosis
50%
Polymorphism
25%
C(T)
25%
5′-end
25%
Race-ethnicity
25%
Tumor Formation
25%
SNP
25%
Non-coding
25%
Highest Gleason Score
25%
Cancer Cases
25%
Chromosome 3
25%
Nonsynonymous
25%
Biochemistry, Genetics and Molecular Biology
Single-Nucleotide Polymorphism
100%
SEMA3F
100%
SEMA3B
100%
Semaphorin
100%
Haplotype
50%
Allele
50%
Carcinogenesis
25%
Case-Control Study
25%
Single Nucleotide Polymorphism
25%
Gleason Score
25%
Chromosome 3
25%
Medicine and Dentistry
Prostate Cancer
100%
Cancer Risk
100%
Single Nucleotide Polymorphism
100%
Semaphorin
100%
Allele
33%
Haplotype
33%
In Vitro
16%
Carcinogenesis
16%
Chromosome 3
16%
Gleason Score
16%
Case-Control Study
16%
Neuroscience
Single-Nucleotide Polymorphism
100%
Semaphorin
100%
Haplotype
50%
In Vivo
25%
In Vitro
25%
Carcinogenesis
25%
Chromosome 3
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Semaphorin
100%
Carcinogenesis
16%
Case-Control Study
16%
Gleason Score
16%
Cancer Prognosis
16%
Immunology and Microbiology
Single Nucleotide Polymorphism
100%
Haplotype
40%
Allele
40%
Gleason Score
20%
Chromosome 3
20%
In Vitro
20%